Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Top Cited Papers
- 1 May 2009
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 10 (5), 501-507
- https://doi.org/10.1016/s1470-2045(09)70035-x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch SyndromeNew England Journal of Medicine, 2008
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in MenGastroenterology, 2008
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trialsAnnals Of The Rheumatic Diseases, 2007
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasNew England Journal of Medicine, 2006
- Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal CancerJAMA, 2005
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized TrialJNCI Journal of the National Cancer Institute, 1993